I-Corps: Novel hydrogels for chronic diseases in pets and livestock
I-Corps:治疗宠物和牲畜慢性疾病的新型水凝胶
基本信息
- 批准号:2327750
- 负责人:
- 金额:$ 5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-15 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact potential of this I-Corps project is a novel approach for the treatment of oral inflammatory and ulcerative diseases in dogs and cats. As the biggest challenge with inflammatory dental disease treatment lies in biofilm reduction, anti-viral mechanisms, immune system modulation, and reduction of inflammation, our solution tackles it all with economically feasible, easy to use, and efficient technology. This innovation will stimulate stem cells to grow and promote wound healing of damaged tissue by maintaining gingival mesenchymal stem cells homeostasis. This novel approach for Feline chronic gingivostomatitis treatment with the application of Lactic Acid Bacteria-derived metabolites and exosomes combined with organic zinc nanoparticles and hydrogel in a formulation.This I-Corps project is based on the development of treatment of periodontal disease, which is the most common infectious condition in adult dogs and cats. It is a progressive, cyclical inflammatory disease of the supporting structures of the tooth and is the main cause of dental disease and early tooth loss in both species. It affects over 87% of dogs and 70% of cats over three years of age. This novel approach uses a hydrogel enriched with paraprobiotics (non-infectious microbial cell components such as peptidoglycans, teichoic acids, surface proteins, etc.) and lactic acid bacteria probiotics derived biomolecules, so-called postbiotics (exosomes, enzymes, secreted proteins, short chain fatty acids, vitamins, secreted biosurfactants, amino acids, peptides, organic acids, etc.) enhanced with biologically produced zinc oxide nanoparticles. This technology will help cats by reducing inflammation, dental plaque, chronic pain, promoting tissue and cell regeneration, treating viral infection, and improving wound healing.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这个I-Corps项目的更广泛的影响潜力是一种治疗犬和猫口腔炎症和溃疡性疾病的新方法。由于炎症性牙病治疗的最大挑战在于生物膜减少、抗病毒机制、免疫系统调节和炎症减少,我们的解决方案通过经济可行、易于使用和高效的技术来解决这一切。这项创新将刺激干细胞生长,并通过维持牙龈间充质干细胞的体内平衡来促进受损组织的伤口愈合。这种新的方法用于猫慢性牙龈口炎的治疗与应用乳酸菌衍生的代谢产物和外泌体结合有机锌纳米颗粒和水凝胶的配方。这个I-Corps项目是基于牙周病治疗的发展,这是成年狗和猫最常见的感染性疾病。它是牙齿支撑结构的进行性、周期性炎症性疾病,是两个物种中牙齿疾病和早期牙齿脱落的主要原因。它影响了超过87%的狗和70%的猫超过三岁。这种新方法使用富含副益生菌(非感染性微生物细胞组分,如肽聚糖、磷壁酸、表面蛋白等)的水凝胶。和乳酸菌益生菌衍生的生物分子,即所谓的益生菌后体(外泌体、酶、分泌蛋白、短链脂肪酸、维生素、分泌生物表面活性剂、氨基酸、肽、有机酸等)。用生物产生的氧化锌纳米颗粒增强。这项技术将通过减少炎症、牙菌斑、慢性疼痛、促进组织和细胞再生、治疗病毒感染以及改善伤口愈合来帮助猫。该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Krzysztof Marycz其他文献
Polyrhodanine cobalt ferrite (PRHD@CoFe<sub>2</sub>O<sub>4</sub>) hybrid nanomaterials - Synthesis, structural, magnetic, cytotoxic and antibacterial properties
- DOI:
10.1016/j.matchemphys.2018.05.015 - 发表时间:
2018-09-15 - 期刊:
- 影响因子:
- 作者:
Emilia Zachanowicz;Jacek Pigłowski;Aleksander Zięcina;Krzysztof Rogacki;Błażej Poźniak;Marta Tikhomirov;Monika Marędziak;Krzysztof Marycz;Joanna Kisała;Kinga Hęclik;Robert Pązik - 通讯作者:
Robert Pązik
Correction: Inhibition of protein tyrosine phosphatase improves mitochondrial bioenergetics and dynamics, reduces oxidative stress, and enhances adipogenic differentiation potential in metabolically impaired progenitor stem cells
- DOI:
10.1186/s12964-023-01055-x - 发表时间:
2023-01-20 - 期刊:
- 影响因子:8.900
- 作者:
Katarzyna Kornicka-Garbowska;Lynda Bourebaba;Michael Röcken;Krzysztof Marycz - 通讯作者:
Krzysztof Marycz
Astaxanthin supplementation in Arabian racing horses mitigates oxidative stress and inflammation in peripheral blood mononuclear cells through enhanced mitophagy
- DOI:
10.1038/s41598-025-93661-7 - 发表时间:
2025-04-26 - 期刊:
- 影响因子:3.900
- 作者:
Beata Giercuszkiewicz-Hecold;David Pajuelo;Zofia Steczkiewicz;Anna Cywinska;Krzysztof Marycz - 通讯作者:
Krzysztof Marycz
Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment
- DOI:
10.1016/j.biopha.2022.113261 - 发表时间:
2022-09-01 - 期刊:
- 影响因子:7.500
- 作者:
Nabila Bourebaba;ThuHa Ngo;Agnieszka Śmieszek;Lynda Bourebaba;Krzysztof Marycz - 通讯作者:
Krzysztof Marycz
Correction: Hyoscyamus albus nortropane alkaloids reduce hyperglycemia and hyperinsulinemia induced in HepG2 cells through the regulation of SIRT1/NF-kB/JNK pathway
- DOI:
10.1186/s12964-023-01056-w - 发表时间:
2023-01-20 - 期刊:
- 影响因子:8.900
- 作者:
Anna Kowalczuk;Nabila Bourebaba;Katarzyna Kornicka-Garbowska;Eliza Turlej;Krzysztof Marycz;Lynda Bourebaba - 通讯作者:
Lynda Bourebaba
Krzysztof Marycz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
- 批准号:82304677
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
- 批准号:82304658
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
- 批准号:82070530
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
- 批准号:32002421
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
- 批准号:31902347
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The impact of age-related vitreous degeneration and vitreous replacement on scleral biomechanics: a novel mechanism and treatment target for glaucoma
年龄相关性玻璃体变性和玻璃体置换对巩膜生物力学的影响:青光眼的新机制和治疗目标
- 批准号:
10647522 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Novel Bioprinted Neural Stem Cell-Embedded Hydrogel Matrices for Enhanced Treatment of Glioblastoma
新型生物打印神经干细胞嵌入水凝胶基质,用于增强胶质母细胞瘤的治疗
- 批准号:
10749330 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Back of the eye drug delivery: Novel contact lenses, pathways, and in-silico modeling
眼后药物输送:新型隐形眼镜、通路和计算机建模
- 批准号:
10735642 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Improving in vitro preantral follicle development using novel bioengineered culture systems and pre-theca-like cells as a strategy for assisted reproduction
使用新型生物工程培养系统和卵泡膜前样细胞作为辅助生殖策略改善体外窦前卵泡发育
- 批准号:
10749434 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs
通过风险分层社区参与计划验证用于早期检测胰腺癌的新型成像和分子测试
- 批准号:
10640704 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Pivotal Preclinical Studies of Novel Infusible ECM for Treating Acute MI
新型不输 ECM 治疗急性 MI 的关键临床前研究
- 批准号:
10699610 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
A novel electric current-based treatment system for chronic wound biofilm infections
一种新型的基于电流的慢性伤口生物膜感染治疗系统
- 批准号:
10720191 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Investigation and biosensing application of novel switching function in conductive polymer hydrogels
导电聚合物水凝胶新型开关功能的研究及生物传感应用
- 批准号:
22KF0095 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Grant-in-Aid for JSPS Fellows
A Novel Fiber Embedded Hydrogel Temporomandibular Joint Disc Replacement
新型纤维嵌入水凝胶颞下颌关节盘置换术
- 批准号:
10893071 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别:
Novel Implementation of Microporous Annealed Particle HydroGel for Next-generation Posterior Pharyngeal Wall Augmentation
用于下一代咽后壁增强的微孔退火颗粒水凝胶的新实现
- 批准号:
10727361 - 财政年份:2023
- 资助金额:
$ 5万 - 项目类别: